About Ripharma
Ripharma is a company based in India. Ripharma offers products and services including Yolovit and Bioeffer.
- Headquarter India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Ripharma Laboratories Ltd
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$3.88 M (USD)13.09as on Mar 31, 2023
-
Net Profit
$270.69 K (USD)91.91as on Mar 31, 2023
-
EBITDA
$197.54 K (USD)80.6as on Mar 31, 2023
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ripharma
Ripharma offers a comprehensive portfolio of products and services, including Yolovit and Bioeffer.
This product is developed as part of innovative health formulations
This formulation is provided within the company's range of advanced pharmaceutical offerings
Funding Insights of Ripharma
Detailed funding history for Ripharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ripharma
Investment portfolio details for Ripharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ripharma
Detailed financials for Ripharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ripharma Comparisons
Peer comparison for Ripharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ripharma
Detailed competitors of Ripharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ripharma
Complete news archive for Ripharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ripharma
Ripharma is headquartered in India.
Annual revenue of Ripharma is $3.88M as on Mar 31, 2023.
Ripharma is recognized as a leading bio-pharmaceutical company in India, having been established in 2005 by professionals committed to fostering good health. The companys operations are known to encompass the full pharmaceutical value chain, including discovery, development, and delivery of innovative formulations. Manufacturing is conducted in units that are accredited with WHO-GMP, ensuring quality is prioritized. Relationships with renowned companies have been built, supporting a strong presence in domestic and international markets, where over 500 products are exported to more than 10 countries. Global alliances are encouraged to provide safer therapies.
Ripharma offers Yolovit and Bioeffer.